Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
HLXC compared with IBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
HLXC
Helix Acquisition Corp. III
Change
Mkt cap
Revenue
Revenue
IBIO
iBio, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
HLXC
Helix Acquisition Corp. III
vs
IBIO
iBio, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
HLXC: latest quarter not drawable. IBIO: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
HLXC, solid
IBIO, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only HLXC
0
None
Shared
0
No disclosed counterparties: HLXC.
Only IBIO
16
TWST
Twist Bioscience
supplier
—
AstralBio
unlisted
supplier
—
Chardan
unlisted
supplier
—
Lonza Sales
unlisted
supplier
12 more · IBIO chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
HLXC
Helix Acquisition Corp. III
Change
10.25
· pre 10.28
· delayed
Mkt cap
$226.6M
Revenue
—
IBIO
iBio, Inc.
Change
0.75
· pre 0.75
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$49.4M
Revenue
$100,000
Q1 FY26
vs
Compare
Pre-market
Oct 30 '26
delayed
HLXC
Helix Acquisition Corp. III
vs
IBIO
iBio, Inc.
10.25
pre 10.28
delayed
Price
0.75
pre 0.75
delayed
$226.6M
Mkt cap
$49.4M
—
Revenue
$100,000
Q1 FY26
Change
Change
HLXC
10.25
vs
IBIO
0.75
Pre-market
Oct 30 '26
delayed